Berndt-Zipfel, C., Michelson, G., Dworak, M., Mitry, M., Löffler, A., Pfützner, A., & Forst, T. (2013). Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study. BioMed Central.
Citação norma ChicagoBerndt-Zipfel, Christine, Georg Michelson, Markus Dworak, Michael Mitry, Andrea Löffler, Andreas Pfützner, and Thomas Forst. Vildagliptin in Addition to Metformin Improves Retinal Blood Flow and Erythrocyte Deformability in Patients With Type 2 Diabetes Mellitus – Results From an Exploratory Study. BioMed Central, 2013.
Citação norma MLABerndt-Zipfel, Christine, et al. Vildagliptin in Addition to Metformin Improves Retinal Blood Flow and Erythrocyte Deformability in Patients With Type 2 Diabetes Mellitus – Results From an Exploratory Study. BioMed Central, 2013.